Janus Henderson Horizon Biotechnology IU2 HEUR (LU2342243362)
40.60
-0.49
(-1.19%)
EUR |
Aug 28 2026
LU2342243362 Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 44.04% |
| June 30, 2026 | 44.04% |
| May 31, 2026 | 44.04% |
| April 30, 2026 | 44.04% |
| March 31, 2026 | 44.04% |
| February 28, 2026 | 44.04% |
| January 31, 2026 | 44.04% |
| Date | Value |
|---|---|
| December 31, 2025 | 44.04% |
| November 30, 2025 | 44.04% |
| October 31, 2025 | 44.04% |
| September 30, 2025 | 44.04% |
| August 31, 2025 | 44.04% |
| July 31, 2025 | 44.04% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Pictet-Biotech-HP EUR | 47.29% |
| MEDICAL BioHealth EUR H | 48.10% |
| Selectra Investments J. Lamarck Biotech A | 50.27% |
| Franklin Biotechnology Discovery I (acc) EUR-H1 | 47.03% |
| DWS ESG Biotech FC | 32.85% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 3.754 |
| Beta (5Y) | 0.6666 |
| Alpha (vs YCharts Benchmark) (5Y) | 8.041 |
| Beta (vs YCharts Benchmark) (5Y) | 0.4176 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 24.36% |
| Historical Sharpe Ratio (5Y) | 0.4595 |
| Historical Sortino (5Y) | 0.7296 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.30% |
Max Drawdown (5Y) Excel Add-In Codes
| Metric Code: max_drawdown_5y |
| Latest Data Point: =YCP("M:LU2342243362", "max_drawdown_5y") |
| Last 5 Data Points: =YCS("M:LU2342243362", "max_drawdown_5y", -4) |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |